Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-02-20
1991-01-15
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31235
Patent
active
049854585
ABSTRACT:
A pharmaceutical composition for the treatment of regressive disorders of the central nervous system treatable by inducing the production and secretion of nerve growth factor, containing as an active ingredient a catechol derivative of the formula ##STR1## where R.sub.6 is a lower alkyl group having 2 to 5 carbon atoms. The catechol derivatives provide preventative and remedial effects for regressive disorders in the central nervous system including senile dementia of the alzheimer type.
REFERENCES:
patent: 3631227 (1971-12-01), Kablaoui et al.
patent: 4559328 (1985-12-01), Smerbeck
patent: 4578210 (1986-03-01), Praefcke et al.
patent: 4593121 (1986-06-01), Okamoto et al.
patent: 4608391 (1986-08-01), Ginos
The Journal of Biological Chemistry, vol. 261, No. 13, May 1986, Y. Furukawa et al., "Catecholamines Induce an Increase in Nerve Growth Factor Content in the Medium of Mouse L-M Cells", p. 6039, abstract; p. 6043, table I; p. 6044, right column, lines 35-46.
Ikeda Fumiaki
Nakayama Shigenobu
Friedman Stanley J.
Hollinden Gary E.
Mitsui Toatsu Chemicals Incorporated
LandOfFree
Catechol diacetate derivatives for inducing the production of ne does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Catechol diacetate derivatives for inducing the production of ne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catechol diacetate derivatives for inducing the production of ne will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-55632